These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35850313)

  • 1. Optimizing component formula suppresses lung cancer by blocking DTL-mediated PDCD4 ubiquitination to regulate the MAPK/JNK pathway.
    Fan Q; Lu Q; Wang G; Zhu W; Teng L; Chen W; Bi L
    J Ethnopharmacol; 2022 Dec; 299():115546. PubMed ID: 35850313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
    Cui H; Wang Q; Lei Z; Feng M; Zhao Z; Wang Y; Wei G
    J Exp Clin Cancer Res; 2019 Aug; 38(1):350. PubMed ID: 31409387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
    Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.
    Yang HS; Matthews CP; Clair T; Wang Q; Baker AR; Li CC; Tan TH; Colburn NH
    Mol Cell Biol; 2006 Feb; 26(4):1297-306. PubMed ID: 16449643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea-derived theabrownin suppresses human non-small cell lung carcinoma in xenograft model through activation of not only p53 signaling but also MAPK/JNK signaling pathway.
    Xiao X; Guo L; Dai W; Yan B; Zhang J; Yuan Q; Zhou L; Shan L; Efferth T
    J Ethnopharmacol; 2022 Jun; 291():115167. PubMed ID: 35271947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.
    Zhen Y; Liu Z; Yang H; Yu X; Wu Q; Hua S; Long X; Jiang Q; Song Y; Cheng C; Wang H; Zhao M; Fu Q; Lyu X; Chen Y; Fan Y; Liu Y; Li X; Fang W
    Cell Death Dis; 2013 Oct; 4(10):e872. PubMed ID: 24157866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition effect of oxyepiberberine isolated from Coptis chinensis franch. On non-small cell lung cancer based on a network pharmacology approach and experimental validation.
    Zhang Y; Yao Y; Fu Y; Yuan Z; Wu X; Wang T; Hong Z; Yang Y; Wu H
    J Ethnopharmacol; 2021 Oct; 278():114267. PubMed ID: 34087401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation.
    Shen L; Ling M; Li Y; Xu Y; Zhou Y; Ye J; Pang Y; Zhao Y; Jiang R; Zhang J; Liu Q
    PLoS One; 2013; 8(3):e57652. PubMed ID: 23469214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pdcd4 knockdown up-regulates MAP4K1 expression and activation of AP-1 dependent transcription through c-Myc.
    Wang Q; Zhang Y; Yang HS
    Biochim Biophys Acta; 2012 Oct; 1823(10):1807-14. PubMed ID: 22801218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Puerarin Inhibits the Proliferation,Invasion,and Migration of Non-small Cell Lung Cancer Cells through Regulating miR-490/Denticleless E3 Ubiquitin Protein Ligase].
    Zhang YX; Zhang ZZ; Zhao LG; Zhao LL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):91-101. PubMed ID: 35300770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosing targets and pharmacological mechanisms of total bioflavonoids extracted from Selaginella doederleinii against non-small cell lung cancer by combination of network pharmacology and proteomics.
    Xu D; Wang X; Huang D; Chen B; Lin X; Liu A; Huang J
    J Ethnopharmacol; 2022 Mar; 286():114836. PubMed ID: 34793885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS
    Pei T; Dai Y; Tan X; Geng A; Li S; Gui Y; Hu C; An J; Yu X; Bao X; Wang D
    J Ethnopharmacol; 2023 Apr; 306():116134. PubMed ID: 36627003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ
    J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shikonin reactivates TSGs GADD45B and PPP3CC to block NSCLC cell proliferation and migration through JNK/P38/MAPK signaling pathways.
    Zhao Y; Wu D; Fu Z; Liu W; Yao Y; Liang Y
    BMC Complement Med Ther; 2024 Jan; 24(1):10. PubMed ID: 38167059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XBP1s promotes the development of lung adenocarcinoma via the p‑JNK MAPK pathway.
    Jiang H; Jiang Q; He Y; Li X; Xu Y; Liu X
    Int J Mol Med; 2022 Mar; 49(3):. PubMed ID: 35059734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology Based Elucidation of Molecular Mechanisms of Laoke Formula for Treatment of Advanced Non-Small Cell Lung Cancer.
    Feng YY; Liu JF; Xue Y; Liu D; Wu XZ
    Chin J Integr Med; 2024 Nov; 30(11):984-992. PubMed ID: 38941043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
    Jiang LP; He CY; Zhu ZT
    Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of programmed cell death 4 (PDCD4) is associated with aromatase inhibitor resistance and a poor prognosis in estrogen receptor-positive breast cancer.
    Chen Z; Yuan YC; Wang Y; Liu Z; Chan HJ; Chen S
    Breast Cancer Res Treat; 2015 Jul; 152(1):29-39. PubMed ID: 26026468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.
    Lin Y; Shen C; Wang F; Fang Z; Shen G
    J Diabetes Res; 2021; 2021():9941791. PubMed ID: 34159207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.